Lexaria Bioscience Corp. (LEXX)

NASDAQ: LEXX · Real-Time Price · USD

0.6225

+0.0022 (0.35%)

At close: Feb 13, 2026, 4:00 PM EST

0.6150

-0.0075 (-1.20%)

After-hours: Feb 13, 2026, 5:52 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020	Aug '19 Aug 31, 2019	Aug '18 Aug 31, 2018	Aug '17 Aug 31, 2017
Intellectual Property Licensing	457.99K
Intellectual Property Licensing Growth	211.98%
Business-to-business Product	5.39K
Business-to-business Product Growth	-87.80%
Research & Development	900.00
Research & Development Growth	-97.45%

Revenue by Geography

Financials in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020	Aug '19 Aug 31, 2019	Aug '18 Aug 31, 2018	Aug '17 Aug 31, 2017
United States and Canada	464.28K
United States and Canada Growth	105.24%